Revista de Farmacología Clínica y Experimental

Perspectiva

PPI Network and GO/KEGG Analyses of Potential Therapeutic Targets for Premature Ovarian Insufficiency (POI)

• Candice Erickson*

Perspectiva

The Role of Pharmacogenetics in Tenofovir Plasma and Urine Exposure Variability

• Kennedy Roger*

Comentario

Pharmacogenetics in Multiethnic Populations and Drug Response in Cardiovascular Disease Treatment

• Michele Benjamin*

Artículo de opinión

Deglycosylation of Ginsenosides by Human Intestinal Bacteria: A Key to Enhanced Bioactivity

• Michael Bates*

Perspectiva

Physicochemical Characteristics of PEG-Polypeptides and Indomethacin-Encapsulated HIP Micelle

• Tessa Puranen*

Comentario

Ultra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS) in Pharmacokinetics: A Revolution in Drug Analysis

• Gila Waldherr*

Comentario

Analytical Approaches for Pharmacokinetic Studies of Nano Drug Delivery Systems

• Christopher Castillo*

Artículo de opinión

Overview on Complex Field of Drug Discovery and Development

• Roberto Denley*

Artículo de revisión

Correlaciones genotipo-fenotipo en miocardiopatías hereditarias, su papel en la toma de decisiones clínicas e implicaciones en la medicina cardíaca personalizada en las eras de la multiómica y del modelado de enfermedades

• Yaqob Samir Taleb*, Paras Memon, Aftab Jalbani, Nouf Al-Mutairi, Sarah Al-Mukhaylid, Nawaf Al Anazi, Abdulkareem Al-Garni, Muneera Altaweel, Muhammad Aamir Khan, Muhammad Farooq Sabar, Zafar Iqbal*